Robeco Schweiz AG Raises Stock Position in Synopsys, Inc. $SNPS

Robeco Schweiz AG grew its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 111.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,500 shares of the semiconductor company’s stock after acquiring an additional 18,200 shares during the period. Robeco Schweiz AG’s holdings in Synopsys were worth $17,022,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. Norges Bank bought a new position in Synopsys in the 2nd quarter worth approximately $647,964,000. Ameriprise Financial Inc. grew its stake in Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after acquiring an additional 585,494 shares in the last quarter. Ninety One UK Ltd purchased a new position in Synopsys during the third quarter valued at $249,851,000. Aspex Management HK Ltd lifted its stake in Synopsys by 106.0% in the 2nd quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after purchasing an additional 332,364 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Synopsys by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after purchasing an additional 231,014 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on SNPS. Citigroup began coverage on Synopsys in a research report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. Piper Sandler downgraded Synopsys from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $602.00 to $520.00 in a research report on Tuesday. KeyCorp boosted their price target on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. BNP Paribas initiated coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Finally, Needham & Company LLC lifted their price objective on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $553.57.

Insiders Place Their Bets

In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is owned by company insiders.

Synopsys Trading Down 4.1%

SNPS stock opened at $511.80 on Wednesday. The firm’s fifty day simple moving average is $448.73 and its two-hundred day simple moving average is $505.02. The stock has a market capitalization of $97.92 billion, a price-to-earnings ratio of 64.06, a price-to-earnings-growth ratio of 4.44 and a beta of 1.12. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the prior year, the firm posted $3.40 EPS. The firm’s revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.